Gu W Y, Zhang L L, Zhang H, Pan Q Z, Qu Y Q, Tao X, Ning Y
Department of Pathology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200090, China.
Zhonghua Bing Li Xue Za Zhi. 2018 Aug 8;47(8):622-626. doi: 10.3760/cma.j.issn.0529-5807.2018.08.010.
To investigate the clinical and pathological characteristics and prognosis of ovarian clear cell borderline tumor. A total of 12 cases of ovarian clear cell borderline tumors recorded were collected from May 2011 to December 2017 at Obstetrics and Gynecology Hospital, Fudan University.Clinical histories were retrieved and pathological slides were reviewed. The age of the patients ranged from 35 to 65 years with a mean age of 52 years. Seven cases were associated with cystic endometriosis of the ovary. All tumors consisted of irregular and crowded glands or cysts embedded in a fibromatous stroma. The cysts and glands were lined by mild to moderate atypical cells.CK7 and HNF-1β were expressed in all cases, and Naspin A was expressed in 11 cases. ARID1A expression was absent in 5 cases and p53 showed wild-type expression. None of the cases developed recurrence during follow-up ranging from 7 to 79 months. Ovarian clear cell borderline tumor may be associated with endometriosis and tumor suppressor gene ARIDA. The tumor has a good prognosis without recurrence and progression to carcinoma.
探讨卵巢透明细胞交界性肿瘤的临床病理特征及预后。收集2011年5月至2017年12月复旦大学附属妇产科医院记录的12例卵巢透明细胞交界性肿瘤病例。检索临床病史并复查病理切片。患者年龄35至65岁,平均年龄52岁。7例与卵巢囊性子宫内膜异位症相关。所有肿瘤均由嵌入纤维瘤样间质中的不规则且密集的腺体或囊肿组成。囊肿和腺体衬以轻度至中度非典型细胞。所有病例均表达CK7和HNF-1β,11例表达Naspin A。5例无ARID1A表达,p53呈野生型表达。随访7至79个月期间,无一例复发。卵巢透明细胞交界性肿瘤可能与子宫内膜异位症和肿瘤抑制基因ARIDA相关。该肿瘤预后良好,无复发及进展为癌的情况。